AI Article Synopsis

  • LVNC is a heart condition characterized by an abnormal growth of muscle tissue, and the role of the protein SORBS2 in exacerbating this condition is under investigation.
  • Researchers used advanced techniques to identify proteins that interact with SORBS2, finding several potential links to the development of LVNC, including proteins like α-actinin and YWHAQ.
  • The study highlights a novel mechanism where the interaction between SORBS2 and YWHAQ may disrupt the normal cell cycle, contributing to the pathology of LVNC.

Article Abstract

Background: Left ventricular noncompaction cardiomyopathy (LVNC) is a cardiac disorder characterized by an excessive trabecular meshwork of deep intertrabecular recesses within the ventricular myocardium. Sorbin and SH3 domain-containing protein 2 (SORBS2) converges on the actin and microtubule cytoskeleton. Here, we investigated the proteins interacting with SORBS2 to elucidate the pathogenic mechanism of LVNC. As reported in previous studies, SORBS2 enhances the occurrence of LVNC by potentiating heart failure, but the specific mechanism remains unclear.

Methods: Building from our previous finding of elevated SORBS2 levels in LVNC hearts, we screened for proteins interacting with SORBS2 by proteomics and conducting IP experiments. Co-IP and immunofluorescence were used to verify the effects.

Results: We selected several proteins with high scores and high coverage that could be closely related to SORBS2 according to earlier reports showing a correlation with LVNC for verification. We finally obtained several proteins that were related to the pathogenesis of LVNC and also interacted with SORBS2, such as α-actinin, β-tubulin, MYH7, FLNA, MYBPC3, YWHAQ and DES, and YWHAQ was the most associated.

Conclusions: We focused on the YWHAQ protein, and we identified a novel mechanism through which SORBS2 interacts with YWHAQ, having a negative effect on the cell cycle, potentially leading to LVNC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833133PMC
http://dx.doi.org/10.18632/aging.203841DOI Listing

Publication Analysis

Top Keywords

sorbs2
9
protein sorbs2
8
pathogenic mechanism
8
lvnc
8
mechanism lvnc
8
proteins interacting
8
interacting sorbs2
8
interaction protein
4
sorbs2 myocardial
4
myocardial tissue
4

Similar Publications

Whole genome and transcriptome analysis of pancreatic acinar cell carcinoma elucidates mechanisms of homologous recombination deficiency and unravels novel relevant fusion events.

Pathol Res Pract

December 2024

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, 1300 York Ave, New York, NY 10065,  USA; Englander Institute for Precision Medicine, Weill Cornell Medicine, 413 East 69th Street, New York, NY 10021, USA. Electronic address:

Pancreatic acinar cell carcinoma (PACC) is a rare pancreatic tumor with a heterogeneous clinical course and, except for radical surgery, limited treatment options. We present a comprehensive study encompassing whole-genome and RNA sequencing of 7 tumor samples from 3 metastatic PACC patients to further delineate its genomic landscape and potential therapeutic implications. Our findings reveal distinct signatures of homologous recombination deficiency (HRD) in patients harboring pathogenic germline BRCA1/2 and FANCL mutations, demonstrating favorable responses to poly (ADP-ribose) polymerase 1 (PARP) inhibitors with prolonged disease-free intervals.

View Article and Find Full Text PDF

Breast cancer (BRCA) is one of the major threats to women's health worldwide. This study focuses on the roles of sorbin and SH3 domain-containing protein 2 (SORBS2) protein and microRNA-138-5p in the progression of BRCA, analyzing their regulatory effects on cancer cell proliferation, cell cycle, and migration ability. Using bioinformatics tools and experimental methods, the study found that SORBS2 is commonly underexpressed in BRCA.

View Article and Find Full Text PDF

SORBS2-Mediated inhibition of malignant behaviors in esophageal squamous cell carcinoma through TIMP3.

Int Immunopharmacol

December 2024

Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China; Department of Cardiothoracic Surgery, Affiliated Hospital of Putian University, Putian, China; Key Laboratory of Ministry of Education for Gastrointestinal Cancer, Fujian Medical University, Fuzhou, China; Fujian Key Laboratory of Tumor Microbiology, Fujian Medical University, Fuzhou, China; Clinical Research Center for Thoracic Tumors of Fujian Province, Fuzhou, China. Electronic address:

Background: Esophageal squamous cell carcinoma (ESCC) is characterized by high invasiveness and poor prognosis. The role of Sorbin and SH3 domain-containing protein 2 (SORBS2) in ESCC remains largely unexplored.

Methods: The expression levels of SORBS2 in ESCC were detected using RNA-seq and proteomics data.

View Article and Find Full Text PDF

Background And Study Aims: The clinicopathological risk factors in the prognosis of stage IV gastric cancer have been comprehensively studied. However, the influencing factors of stage IV gastric cancer prognosis at genomic and transcriptional levels have not been well defined.

Patients And Methods: The mutational and transcriptional data, along with demographic, clinicopathological and prognostic information of 44 stage IV gastric cancer patients were downloaded from the TCGA database.

View Article and Find Full Text PDF
Article Synopsis
  • - SORBS2 is an RNA-binding protein that regulates aerobic glycolysis, crucial for placenta development and trophoblast migration, essential processes for successful pregnancy.
  • - In preeclampsia, reduced levels of SORBS2 impair trophoblast migration by affecting the stability of mRNA related to glycolysis, which may lead to complications in placentation.
  • - The study reveals that SORBS2 enhances the stability of the glycolysis gene HK2, promoting cell migration and proliferation; silencing HK2 negates the positive effects of SORBS2, linking it to preeclampsia pathogenesis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!